Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2023-09-12
2043-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the event of pre-existing kidney damage (glomerular and tubular diseases, stone disease, high blood pressure (hypertension) etc...) these adaptations will not be optimal. This will have implications for:
* the course of the pregnancy with the occurrence of feto-maternal complications: miscarriages, pre-eclampsia, intrauterine growth retardation (IUGR), low birth weight, prematurity. The risk of feto-maternal complications increases with the degree of renal failure or with certain pathologies such as lupus.
* progression of kidney disease
Some maternal complications have long-term implications: preeclampsia is associated with a high risk of subsequent cardiovascular and renal complications. Pregnancies in these patients are high-risk pregnancies and require specialized management by an experienced group of gynecologists and nephrologists.
The creation of a retrospective and prospective register by collecting demographic, clinical, biological, radiological and genetic data concerning patients at each consultation within the CHU Brugmann Hospital will allow:
* to establish the epidemiological and clinico-biological characteristics of the patients followed at the Kidney and Pregnancy Clinic at the CHU Brugmann Hospital
* to analyze the risk factors for feto-maternal complications
* to analyze the risk factors for the occurrence of subsequent cardio-renal pathologies in patients who have had preeclampsia or an event during their pregnancy
* to identify patients who will need specialized genetic testing
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PREDICT: Thinking About Pregnancy Risk in Women With Kidney Disease
NCT04370769
Pregnancy-associated Progression of Chronic Kidney Disease: A Study Protocol for the Development and Validation of a Clinical Predictive Tool
NCT05793346
Patient Presented With AKI Related to Pregnancy
NCT06601374
Determination of Kidney Function
NCT00001978
Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies
NCT06347029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kidney and Pregnancy clinic consultations
Patients followed at the Kidney and Pregnancy clinic pre-conception, during pregnancy and postpartum and patients subsequently referred to nephrological follow-up
Data extraction from medical files
Data extraction from medical files
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data extraction from medical files
Data extraction from medical files
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Woman of childbearing age with:
* Renal damage (glomerular, tubular disease, renal lithiasis, systemic disease, metabolic diseases, congenital diseases, etc.)
* Hematological disorders (sickle cell disease)
* Kidney transplantation
* High blood pressure (hypertension)
* Pre-kidney transplant assessment in progress for discussion of contraception and pregnancy after kidney transplantation
* Preeclampsia
* Multiple miscarriages
* IUGR and low birth weight in the fetus
* Family history of kidney disease
2. Peri-gravid consultations
Pregnant women with
* Pre-existing kidney damage
* De novo renal failure (IR)
* Proteinuria
* Hematuria
* Chronic hypertension
* Pregnancy hypertension
* Renal lithiasis
3. Postpartum consultations
Postpartum women with
* Early/late pre-eclampsia
* Eclampsia / Hemolysis Elevated Liver enzymes Low Platelet (HELLP) syndrome
* Pregnancy hypertension
* Postpartum hemorrhage
* De novo renal failure postpartum
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brugmann University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tatiana Besse-Hammer
Head of clinical research unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christelle Fosso
Role: PRINCIPAL_INVESTIGATOR
CHU Brugmann
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Brugmann
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUB-BrugKidPreg Reg
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.